arrow
J

Juan Sáinz

bio-sanitary institute granada
H指数:26
被引数:2,178

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hybrid Ammonium-M(II) Hydrogenophosphite Hydrates as Bioactive Metal Complexes: Synthesis, DFT and Hirshfeld Surface Analysis, and Anticancer and Anti-Inflammatory Activities

杂交铵-M(II)次磷酸盐水合物作为生物活性金属配合物:合成、DFT和Hirshfeld表面分析及抗癌和抗炎活性

2026-08-270
OA
Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications

多发性骨髓瘤的遗传架构:从体细胞变异到生殖系易感性和临床意义

2026-05-010
OAAI
Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives

非编码RNA作为胰腺癌的生物标志物和治疗靶点:临床意义与转化展望

2026-04-200
OAAI
Identification of four autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

鉴定四种自噬相关遗传变异为慢性淋巴细胞白血病的风险因素

2025-09-050
OAAI
A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers

一项全基因组关联研究确定了与SARS-CoV-2 mRNA-1273疫苗应答相关的新位点,研究对象为健康医疗工作者队列。

2025-08-190
OA
The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC

PDAC的暴露组和胰腺癌,生活方式和环境危险因素

2025-06-100
OA
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization

自噬相关基因的多态性作为胰腺癌的易感性生物标志物: 对三个大型欧洲队列和功能特征的荟萃分析

2024-09-251
OA
Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis
2024-01-181
OAAI
Identification of novel genetic loci for risk of multiple myeloma by functional annotation
LEUKEMIA
IF13.4
2023-09-182
OAAI
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy

免疫化疗一线治疗滤泡性淋巴瘤4项预后指标的评价

2023-04-256
OAAI
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk
2022-10-010
OA
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
2022-06-143
PRE
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study
2022-05-171
OAAI